Study conducted by 13 organisations found that in govt hospitals, direct median total cost for treating bloodstream infections triggered by antimicrobial-resistant bacteria was Rs 89,377.
Mumbai-based Wockhardt has completed phase 3 clinical trials in nearly 400 patients. Pharma firm looking to file for regulatory approvals in India, US and other countries in 2025.
Study by scientists associated with ICMR, Cambridge University and Christian Medical College (CMC), Vellore, was published Tuesday in the Journal of Epidemiology and Global Health.
Findings published Tuesday also said that over 39 crore deaths caused directly or indirectly by antibiotic-resistant infections are estimated to occur worldwide by 2050.
In their findings published in peer-reviewed journal PNAS, Australian scientists say antidepressants trigger defence mechanisms in bacteria causing them to resist antibiotics.
A European Centre for Disease Prevention and Control report said that reported cases of two highly drug-resistant pathogens increased in 2020 and then sharply jumped in 2021.
The spread of SARS-CoV-2 shows just how fast infectious agents can move with human travel. The impact of increasing antibiotic resistance is no different.
A stunted middle class may be a direct result of extreme inequality. Folks at the top don’t see teeming masses as a meaningful market, except for utilities, soap, short videos, and personal loans.
While the commission didn’t mention provisions under which IndiGo's market domination would be examined, Competition Act 2002 prohibits abuse of dominant position by any enterprise.
It is argued that India-Israel ties are moving from buyer–seller dynamic to one focused on joint development & manufacturing partnership, a shift 'more durable' than traditional arms sales.
Don’t blame misfortune. This is colossal incompetence and insensitivity. So bad, heads would have rolled even in the old PSU-era Indian Airlines and Air India.
COMMENTS